BioLife Solutions, Inc. (BLFS)
NASDAQ: BLFS · Real-Time Price · USD
25.48
+0.11 (0.43%)
At close: Dec 3, 2025, 4:00 PM EST
25.51
+0.03 (0.12%)
After-hours: Dec 3, 2025, 4:45 PM EST
BioLife Solutions Market Cap
BioLife Solutions has a market cap or net worth of $1.23 billion as of December 3, 2025. Its market cap has increased by 22.72% in one year.
Market Cap
1.23B
Enterprise Value
1.15B
1-Year Change
22.72%
Ranking
Category
Stock Price
$25.48
Market Cap Chart
Since December 3, 2020, BioLife Solutions's market cap has increased from $1.20B to $1.23B, an increase of 1.86%. That is a compound annual growth rate of 0.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 2, 2025 | 1.21B | 1.16% |
| Dec 31, 2024 | 1.20B | 64.58% |
| Dec 29, 2023 | 728.37M | -6.48% |
| Dec 30, 2022 | 778.80M | -50.26% |
| Dec 31, 2021 | 1.57B | 18.11% |
| Dec 31, 2020 | 1.33B | 10.08% |
| Dec 3, 2020 | 1.20B | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 936.68B |
| Johnson & Johnson | 494.92B |
| AbbVie | 396.55B |
| UnitedHealth Group | 293.98B |
| AstraZeneca | 282.37B |
| Novartis AG | 253.36B |
| Merck & Co. | 250.76B |
| Abbott Laboratories | 219.65B |